TNBI | Tanke Biosciences Corporation Annual & Quarterly

Annual Cash Flows

(In USD)

Breakdown	2023	2022	2021	2020	2019	2012
Operating Cash Flow	-74.66 Thousand	-59.17 Thousand	-3530.00	-	-	-1.18 Million
Net Income	-82.52 Thousand	-98.15 Thousand	-722.98 Thousand	-	-	-229 Thousand
Depreciation & Amortization	8500.00	-	-	-	-	636.28 Thousand
Deferred income taxes	-	-	-	-	-	19 Thousand
Stock-based compensation	-	70.00	663.00	-	-	-
Change in working capital	19.79 Thousand	3348.00	1640.00	-	-	-5.27 Million
Other non-cash items	-14.43 Thousand	35.62 Thousand	717.81 Thousand	-	-	3.68 Million
Investing Cash Flow	-	-	-	-	-	-1.52 Million
Investments in PPE	2.00	-	-	-	-	-1.33 Million
Acquisitions	-	-	-	-	-	190.07 Thousand
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-860.57 Thousand
Financing Cash Flow	70 Thousand	25 Thousand	45.02 Thousand	-	-	1.12 Million
Debt repayment	-70 Thousand	-25 Thousand	-45 Thousand	-	-	-646.85 Thousand
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	-	-	-	-	-	-
Other Financing Activities	-	25.00	25.00	-	-	1.12 Million
Accounts receivables	-	-	-	-	-	-172.38 Thousand
Accounts payables	11 Thousand	-	-	-	-	-138.12 Thousand
Inventory	-	-	-	-	-	-227.08 Thousand
Other working capital	8797.00	3348.00	1640.00	-	-	-4.73 Million
Cash at beginning of period	7318.00	41.49 Thousand	-	-	-	7.7 Million
Cash at end of period	2656.00	7318.00	41.49 Thousand	-	-	6.16 Million
Capital Expenditure	2.00	-	-	-	-	-1.33 Million
Effect of forex changes on cash	-	-	-	-	-	57.73 Thousand
Net cash flow / Change in cash	-4662.00	-34.17 Thousand	41.49 Thousand	-	-	-1.53 Million
Free Cash Flow	-74.66 Thousand	-59.17 Thousand	-3530.00	-	-	-2.52 Million

Breakdown	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2	2023 Q1
Operating Cash Flow	-	-	-	-	-	-
Net Income	-37.71 Thousand	-82.52 Thousand	-30.42 Thousand	9289.00	-15.57 Thousand	-34.95 Thousand
Depreciation & Amortization	-	8500.00	-	8304.00	-	196.00
Deferred income taxes	-	-	-	-	-	-
Stock-based compensation	-	-	-	-	-	-
Change in working capital	24.37 Thousand	19.79 Thousand	13.2 Thousand	5083.00	-	1506.00
Other non-cash items	-24.37 Thousand	-14.43 Thousand	-	-101.08 Thousand	-0.03	86.79 Thousand
Investing Cash Flow	-	-	-	80 Thousand	-	-80 Thousand
Investments in PPE	-	-	-	-	-	-
Acquisitions	-	-	-	80 Thousand	-	-80 Thousand
Investment purchases	-	-	-	-	-	-
Sales/Maturities of investments	-	-	-	-	-	-
Other Investing Activities	-	-	-	-	-	-
Financing Cash Flow	10.72 Thousand	70 Thousand	15 Thousand	-	25 Thousand	30 Thousand
Debt repayment	-	-70 Thousand	-15 Thousand	-	-25 Thousand	-30 Thousand
Dividends payments	-	-	-	-	-	-
Common Stock Repurchased	-	-	-	-	-	-
Common Stock Issuance	726.00	-	-	-	-	-
Other Financing Activities	10 Thousand	-	-	-	-	-
Accounts receivables	-	-	-	-	-	-
Accounts payables	24.37 Thousand	11 Thousand	-	-	-	-
Inventory	-	-	-	-	-	-
Other working capital	-	8797.00	2208.00	5083.00	-	1506.00
Cash at beginning of period	2656.00	7318.00	4871.00	12.82 Thousand	10.46 Thousand	7318.00
Cash at end of period	46.00	2656.00	2656.00	4871.00	12.82 Thousand	10.46 Thousand
Capital Expenditure	-	-	-	-	-	-
Effect of forex changes on cash	-	-	-	-	-	-
Net cash flow / Change in cash	-2610.00	-4662.00	-2215.00	-7949.00	2358.00	3144.00
Free Cash Flow	-13.33 Thousand	-74.66 Thousand	-17.21 Thousand	-95.01 Thousand	-15.57 Thousand	53.14 Thousand